|
|
|
|
Direct and indirect cost burden is higher in HCV infection compared with a matched non-HCV infected cohort in a privately-insured population
|
|
|
Reported by Jules Levin
EASL 2013 April 24-28 Amsterdam
Neeta Tandon1, K. Rajender Reddy2, Patrick Lefebvre3, Helene Parise3, Francois Laliberte3, Dominic Pilon3, Mei S. Duh4, Avinash Prabhakar6, Michelle Cho6, Luis A. Balart5, John Fastenau1
1Janssen Scientific Affairs, LLC, Titusville, NJ, USA; 2Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, PA, USA; 3Groupe d'analyse, Ltee, Montreal, QC, Canada; 4Analysis Group, Inc., Boston, MA, USA; 5Department of Medicine, Gastroenterology and Hepatology, Tulane University Health Sciences Center, New Orleans, LA, USA; 6Janssen Services, LLC, Titusville, NJ, USA
|
|
|
|
|
|
|